We are very proud to announce the publication of our UK national audit of endocrine departments which reveals the extent of the clinical need for improvements in the routine care of those with chronic hypoparathyroidism…. [Read More]
To mark Awareness Month we have added a new page to the website of patient videos to highlight the challenges of living with Primary Hyperparathyroidism. First, we bring you a compelling slideshow by patient expert… [Read More]
The latest update on the Natpar shortages from Takeda are as follows: 100mcg dose – shortage duration is now unknown but is expected to last at least 6 months. 75mcg dose – shortage expected later… [Read More]
Great news to see on World Hypopara Awareness Day 2022! ”Amolyt Pharma announces positive results from phase 2a trial of AZP-3601 for the treatment of hypoparathyroidism.” Read more here https://amolytpharma.com/…/amolyt-pharma-announces…/
Update 1st July 2022 The latest update on the Natpar shortages from Takeda are as follows: 100mcg dose – shortage duration is now unknown but is expected to last at least 6 months. 75mcg dose… [Read More]
Fittingly, we launch our #HypoparaDay2022 campaign today, on #EuropeanHormoneDay. Every day up to June 1st look out for our short videos made to highlight the lifelong impact of the different types of hypopara which all… [Read More]
Parathyroid UK supports the first European Hormone Day launched on 23rd May 2022. #HormoneDay2022 “Why do hormones need a dedicated day?” It’s creator, the European Society of Endocrinology, explains:. “Because cancer is Europe’s second greatest… [Read More]
Congratulations to Professor Karim Meeran who has won the SfE award for Outstanding Clinical Practitioner this year. Prof Meeran is Head of Speciality for Endocrinology at Imperial College Healthcare NHS Trust one of the highest… [Read More]
We are delighted to inform you that Parathyroid UK is now a Patient Advocacy Group Affiliate Member of the European Society of Endocrinology. This initiative is an important step which marks the change in attitudes… [Read More]
We wish you all a hopeful and healthy New Year. With a major national review of endocrinology management out recently and new guidelines on hypo- and hyperparathyroidism soon to be published as well as a… [Read More]
